Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANXA11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SIPA1L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C9orf66 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BPTF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00536 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ELFN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C21orf33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NACC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4755 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929528 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSPH4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARCKS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSACC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on